Mark Leuchtenberger
Président chez NEUROSENSE THERAPEUTICS LTD.
Fortune : 80 640 $ au 30/04/2024
Provenance du réseau au premier degré de Mark Leuchtenberger
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Wake Forest University
47
| College/University | Other Consumer Services | 47 |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ.
18
| Extinct | Biotechnology | 18 |
| Unknown | 15 | ||
| Subsidiary | Pharmaceuticals: Major | 12 | |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom.
9
| Holding Company | Biotechnology | 9 |
Therion Biologics Corp.
 Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Therion Biologics Corp. developed therapeutic vaccines for cancer patients. The company was founded on May 5, 1991 and was headquartered in Cambridge, MA.
6
| Extinct | Pharmaceuticals: Major | 6 |
Mercator Therapeutics, Inc.
 Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mercator Therapeutics develops novel cancer drugs. It is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. The company was founded by Wadih Arap, Renata Pasqualini, Roy Lobb, Mark Leuchtenberger, and Christopher Guiffre in 2009 is headquartered in Wellesley, MA.
4
| Extinct | Pharmaceuticals: Major | 4 |
NeuroHealing Pharmaceuticals, Inc.
 NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
| Public Company | Pharmaceuticals: Major | 3 | |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY.
2
| Extinct | Pharmaceuticals: Major | 2 |
| Public Company | Pharmaceuticals: Major | 2 | |
| Public Company | Pharmaceuticals: Major | 2 | |
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark Leuchtenberger via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| HILLSHIRE BRANDS CO | Food: Meat/Fish/Dairy | Corporate Officer/Principal Corporate Officer/Principal | |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | President Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Wake Forest School of Medicine | College/University | Chairman Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Human Resources Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Corporate Officer/Principal | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Wake Forest Baptist Medical Center
 Wake Forest Baptist Medical Center Medical/Nursing ServicesHealth Services Wake Forest Baptist Medical Center operates as a medical center. It provides volunteer services such as application process, adult volunteers, college student volunteer program and summer volunteer program. The company was founded in 1834 and is headquartered in Winston-Salem, NC. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| Ben-Gurion University of the Negev | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Biotechnology | Founder Founder | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Masters Business Admin | |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co. LLC is a venture capital firm founded by Lawrence Miller and Paul Howard in 1999. It is headquartered in Newton, Massachusetts. | Investment Managers | Chairman Corporate Officer/Principal | |
| NEURODERM LTD | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Indiana University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Clayton Associates Holdings LLC
 Clayton Associates Holdings LLC Investment ManagersFinance Clayton Associates LLC (Clayton Associates) is a venture capital firm founded in 1996 by Stuart C. McWhorter and R. Clayton McWhorter. The firm is headquartered in Brentwood, Tennessee. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Dioko Ventures
 Dioko Ventures Investment ManagersFinance Dioko Ventures (Dioko Ventures) is a venture capital subsidiary of Clayton Associates Holdings LLC. The firm is headquartered in Winston-Salem, North California. | Investment Managers | Private Equity Investor Consultant / Advisor | |
American Association for Physician Leadership, Inc.
 American Association for Physician Leadership, Inc. General GovernmentGovernment American Association for Physician Leadership, Inc. is a non-profit organization that provides leadership education, management training, and career development for physicians. The company was founded by Roger Schenke in 1975 and is headquartered in Tampa, FL. | General Government | Corporate Officer/Principal Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Kucera Pharmaceutical Co.
 Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
PhageNova Bio, Inc.
 PhageNova Bio, Inc. BiotechnologyHealth Technology PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin. | Biotechnology | Founder Founder | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Packaged Software | Director of Finance/CFO Founder | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Masters Business Admin | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| Bar-Ilan University | College/University | Doctorate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Director/Board Member Doctorate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 42 |
| Israël | 7 |
| Royaume-Uni | 2 |
| France | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 17 |
| Finance | 8 |
| Consumer Non-Durables | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 409 |
| Corporate Officer/Principal | 233 |
| Independent Dir/Board Member | 79 |
| Chief Executive Officer | 75 |
| Undergraduate Degree | 62 |
Relations les plus connectées
| Insiders | |
|---|---|
| Matthew King | 47 |
| Jay Venkatesan | 30 |
| David W. Dupree | 28 |
| Harold Rosser | 26 |
| William Greene | 26 |
| James Tobin | 26 |
| C. Nye | 23 |
| Rosemary Crane | 23 |
| Christine Pellizzari | 22 |
| Lars Nelson | 22 |
| Ekaterina Smirnyagina | 21 |
| H. Culp | 21 |
| Cary Claiborne | 19 |
| Walter Ogier | 18 |
| Thomas Schuetz | 17 |
- Bourse
- Insiders
- Mark Leuchtenberger
- Connexions Sociétés